Nephro-Urology Monthly

Published by: Kowsar

Oxalate Nephropathy Causing Irreversible Renal Failure After Roux-en-Y Gastric Bypass Surgery

Fatemeh Yaghoubi 1 , 2 and Maliheh Yarmohamadi 3 , *
Authors Information
1 Department of Nephrology, Tehran University of Medical Sciences, Tehran, Iran
2 Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Internal Medicine, Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran
Article information
  • Nephro-Urology Monthly: 11 (1); e80757
  • Published Online: February 5, 2019
  • Article Type: Case Report
  • Received: June 12, 2018
  • Accepted: November 24, 2018
  • DOI: 10.5812/numonthly.80757

To Cite: Yaghoubi F, Yarmohamadi M. Oxalate Nephropathy Causing Irreversible Renal Failure After Roux-en-Y Gastric Bypass Surgery, Nephro-Urol Mon. Online ahead of Print ; 11(1):e80757. doi: 10.5812/numonthly.80757.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
References
  • 1. Chang AR, Grams ME, Navaneethan SD. Bariatric surgery and kidney-related outcomes. Kidney Int Rep. 2017;2(2):261-70. doi: 10.1016/j.ekir.2017.01.010. [PubMed: 28439568]. [PubMed Central: PMC5399773].
  • 2. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010;20(3):308-15. doi: 10.1007/s11695-009-0026-1. [PubMed: 20217955]. [PubMed Central: PMC2891346].
  • 3. Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332-8. doi: 10.1016/j.soard.2009.08.009. [PubMed: 19846351]. [PubMed Central: PMC2888958].
  • 4. Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009;5(6):662-5. doi: 10.1016/j.soard.2009.01.006. [PubMed: 19359221].
  • 5. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-52. doi: 10.1056/NEJMoa066254. [PubMed: 17715408].
  • 6. Nguyen NT, Silver M, Robinson M, Needleman B, Hartley G, Cooney R, et al. Result of a national audit of bariatric surgery performed at academic centers: A 2004 university health system consortium benchmarking project. Arch Surg. 2006;141(5):445-9. discussion 449-50. doi: 10.1001/archsurg.141.5.445. [PubMed: 16702515].
  • 7. Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72(1):100-7. doi: 10.1038/sj.ki.5002194. [PubMed: 17377509].
  • 8. Shinogle JA, Owings MF, Kozak LJ. Gastric bypass as treatment for obesity: Trends, characteristics, and complications. Obes Res. 2005;13(12):2202-9. doi: 10.1038/oby.2005.273. [PubMed: 16421356].
  • 9. Nagaraju SP, Gupta A, McCormick B. Oxalate nephropathy: An important cause of renal failure after bariatric surgery. Indian J Nephrol. 2013;23(4):316-8. doi: 10.4103/0971-4065.114493. [PubMed: 23960354]. [PubMed Central: PMC3741982].
  • 10. Nasr SH, D'Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, et al. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: An underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3(6):1676-83. doi: 10.2215/CJN.02940608. [PubMed: 18701613]. [PubMed Central: PMC2572276].
  • 11. Chou CW, Teng CJ, Hwang WL. Oxalate nephropathy related end-stage renal disease in a gallbladder cancer patient after Roux-en-Y surgery. J Cancer Res Pract. 2016;3(3):94-5. doi: 10.1016/j.jcrpr.2016.05.005.
  • 12. Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1(5):481-5. doi: 10.1016/j.soard.2005.07.002. [PubMed: 16925274].
  • 13. Agrawal V, Wilfong JB, Rich CE, Gibson P C. Reversal of gastric bypass resolves hyperoxaluria and improves oxalate nephropathy secondary to Roux-en-Y gastric bypass. Case Rep Nephrol Dialysis. 2016;6(3):114-9. doi: 10.1159/000449128.
  • 14. Verdelho M, Mendes M, Ribeiro F. Oxalate nephropathy following Roux en Y gastric bypass surgery: Mini review. Port J Nephrol Hypert. 2016;30(3).

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments